A recent review of the effects of PGC-1α on AD pathophysiology suggest that PGC-1α could improve oxidative stress, mitochondrial dysfunction, and insulin resistance, thereby preventing neuronal cell damage and ameliorating cognitive impairment in AD [48]. This evidence concerns the gene PPARGC1A and Insulin resistance.